This is another name for a type of iron medicine used to treat low iron levels in the blood. It's a specific form of iron that helps your body absorb it better, especially if you have kidney problems or can't take iron pills easily. It's often given through an IV (a vein).
Every report comes from a Lived member, sent anonymously.
Have you tried Ferrosoferric Oxide for Iron-Deficiency Anemia?
Ferrosoferric oxide is the chemical name for magnetite, a magnetic form of iron oxide. In medicine it matters as the iron core of ferumoxytol, sold as Feraheme and as a generic. Ferumoxytol is iron given through a vein (intravenous or IV iron) to treat iron deficiency anemia in adults, meaning a low red blood cell count caused by running short of iron. It is approved for two groups of adults: people whose iron deficiency anemia has not improved with iron tablets, or who cannot tolerate them, and people with chronic kidney disease, in whom iron pills often work poorly. It is not an oral supplement and is not approved for children. A separate brand, Ferabright, contains the same ingredient but is used for a different purpose: as a contrast agent that helps show brain tumors on MRI (magnetic resonance imaging) scans in adults. This page focuses on ferumoxytol as an iron treatment.
The body needs iron to make hemoglobin, the protein in red blood cells that carries oxygen. When iron runs low, the bone marrow cannot make enough healthy red cells, which leads to tiredness, shortness of breath and other symptoms of anemia. Each ferumoxytol particle is a tiny core of iron oxide wrapped in a sugar-based coating. The coating keeps the iron from reacting in the bloodstream. Immune cells in the liver, spleen and bone marrow take up the particles and release the iron, which is then either stored (as ferritin) or carried to the bone marrow to build new hemoglobin. Because the iron goes straight into the blood, it bypasses the gut, which is why it can work when tablets are not absorbed or cause too many stomach problems.
Ferumoxytol is given only as an IV infusion in a clinic, infusion center or dialysis unit. The usual course is two doses of 510 milligrams of iron, given 3 to 8 days apart. Each infusion runs for at least 15 minutes, while the person sits reclined or semi-reclined, and the team checks blood pressure and pulse during the infusion and for at least 30 minutes afterward. For people on hemodialysis, it is usually given once blood pressure is stable, at least an hour into a dialysis session. If iron deficiency persists or comes back later, the same course can be repeated. Tell the nurse right away if the infusion site becomes painful or swollen: if the medicine leaks outside the vein it can leave a brown stain on the skin that may last a long time.
Side effects are usually mild; the most commonly reported are headache, nausea, dizziness, diarrhea, constipation, a drop in blood pressure and swelling in the legs or ankles. The main serious risk is an allergic reaction, including anaphylaxis, a severe whole-body reaction that can be fatal. This carries a boxed warning from the US Food and Drug Administration (FDA), the agency's most prominent safety warning. It is uncommon (about 4 in 1,000 people had a hypersensitivity reaction in the largest trial using the current infusion method) and can happen even with a later dose after an earlier one went smoothly. Severe reactions can show up as a sudden drop in blood pressure, fainting or collapse. This is why ferumoxytol is given only where staff and treatment for these reactions are immediately available, with observation afterward. Tell the staff at once about rash, itching, dizziness, light-headedness, swelling or any trouble breathing during or after the infusion. If trouble breathing, swelling of the face or throat, or fainting begins after you have left the clinic, call 911.
Ferumoxytol is not given to anyone who has had an allergic reaction to ferumoxytol or to any IV iron product. People with several drug allergies have a higher risk of a serious reaction and should make sure the team knows. Older adults with serious heart, kidney or other health problems can have more severe outcomes if a reaction or a drop in blood pressure occurs, so the decision deserves extra care. It is also not given to people who already have too much iron (iron overload), and repeated courses are guided by blood tests so iron does not build up in the body. Because it puts iron directly into the blood, there is usually no reason to keep taking iron tablets at the same time, and ferumoxytol may reduce their absorption. Ferumoxytol is magnetic and can change how MRI scans look for up to 3 months after the last dose. If an MRI is planned, it is best done first; otherwise, tell the imaging team about the infusion so they can adjust the scan. It does not affect X-rays, CT or PET scans, or ultrasound. For about a day after a dose, routine blood tests can also overstate iron levels. Information on use in pregnancy is limited. Untreated iron deficiency anemia in pregnancy carries its own risks, but a severe reaction or drop in blood pressure in the mother can slow the baby's heart rate, especially later in pregnancy. Anyone pregnant or breastfeeding should weigh the options with their clinician.
Each visit includes the infusion itself and at least 30 minutes of observation afterward, after which people generally go home. In trials in adults whose anemia had not responded to iron tablets, most people's hemoglobin rose by 2 g/dL (grams per deciliter) or more within five weeks, a substantial rise toward the normal range, and people reported less tiredness than those given a dummy infusion (placebo). In people with chronic kidney disease the average rise was smaller, about 1 g/dL. Feeling better tends to follow as the body builds new red blood cells over several weeks. Blood tests are checked at least a month after the second dose: hemoglobin to see whether anemia is improving, and ferritin and transferrin saturation (measures of stored and circulating iron) to see whether iron stores have been refilled. Ferumoxytol corrects the shortage, not its cause. If the underlying reason, such as heavy periods, bleeding in the gut or kidney disease, continues, iron can run low again and another course may be needed, so finding and treating the cause is part of the plan.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Ferrosoferric Oxide, what you've noticed, or ask the community a question.